BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6125825)

  • 1. Psoriasis and leukotriene B4.
    Brain SD; Camp RD; Dowd PM; Black AK; Woollard PM; Mallet AI; Greaves MW
    Lancet; 1982 Oct; 2(8301):762-3. PubMed ID: 6125825
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
    Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
    J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical disorders in psoriasis].
    ToruĊ„ B
    Wiad Lek; 1986 Feb; 39(3):198-202. PubMed ID: 3012888
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotactic leukotrienes in psoriasis.
    Grabbe J; Czarnetzki BM; Mardin M
    Lancet; 1982 Dec; 2(8313):1464. PubMed ID: 6129537
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
    Voorhees JJ
    Arch Dermatol; 1983 Jul; 119(7):541-7. PubMed ID: 6305285
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
    Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
    Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation.
    Kragballe K; Voorhees JJ
    Acta Derm Venereol Suppl (Stockh); 1985; 120():12-7. PubMed ID: 3010612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukotrienes and monohydroxy fatty acids: controversial role in the pathogenesis of psoriasis].
    Ruzicka T
    Hautarzt; 1985 May; 36(5):255-8. PubMed ID: 2989218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calmodulin and psoriasis].
    Humbert P; Renaud A; Zultak M; Laurent R; Agache P
    Ann Dermatol Venereol; 1987; 114(10):1253-5. PubMed ID: 2829689
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandins and dermatology. The Ingram Lecture 1982.
    Greaves MW
    J R Coll Physicians Lond; 1982 Oct; 16(4):219-25. PubMed ID: 6292411
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils.
    Showell HJ; Naccache PH; Borgeat P; Picard S; Vallerand P; Becker EL; Sha'afi RI
    J Immunol; 1982 Feb; 128(2):811-6. PubMed ID: 6274960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulators of cutaneous inflammation and proliferation in psoriasis.
    Kragballe K; Fisher G; Voorhees JJ
    Immunol Ser; 1989; 46():403-24. PubMed ID: 2518721
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasis.
    Camp RD; Mallet AI; Cunningham FM; Wong E; Woollard PM; Dowd P; Kobza Black A; Greaves MW
    Br J Dermatol; 1985 Jul; 113 Suppl 28():98-103. PubMed ID: 2990521
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukotriene B4 and neutrophil function: a review.
    Ford-Hutchinson AW
    J R Soc Med; 1981 Nov; 74(11):831-3. PubMed ID: 6271967
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased levels of leukotriene B4 and interleukin-8 in psoriatic skin.
    Degiulio R; Montemartini C; Mazzone A; Pasotti D; Donadini A; Ricevuti G
    Ann N Y Acad Sci; 1993 Jun; 685():614-7. PubMed ID: 8395781
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of dietary oils and polyunsaturated fatty acids in the management of cutaneous disorders.
    Ziboh VA
    Arch Dermatol; 1989 Feb; 125(2):241-5. PubMed ID: 2913961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.
    Klickstein LB; Shapleigh C; Goetzl EJ
    J Clin Invest; 1980 Nov; 66(5):1166-70. PubMed ID: 6253525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight leukocyte chemotactic factors in psoriatic scales: contribution of lipid-soluble factors to the chemotactic activity.
    Takematsu H; Kato T; Tagami H
    J Dermatol; 1988 Aug; 15(4):287-93. PubMed ID: 2848878
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous responses to lipoxygenase products of arachidonic acid.
    Dowd PM; Greaves MW
    Acta Derm Venereol Suppl (Stockh); 1985; 120():18-22. PubMed ID: 3010613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.